{
  "drug_name": "Naltrexone",
  "url": "https://wikem.org/wiki/Naltrexone",
  "scraped_at": "2026-01-10T07:58:00.405288",
  "sections": {
    "Administration": {
      "text": "Type: Opioid antagonist\nDosage Forms:\nRoutes of Administration: PO, IM\nCommon Trade Names: ReVia, Vivitrol, Depade",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adult_Dosing": {
      "text": "Opioid dependence (prevention of relapse after opioid-free x 7-10d), ETOH dependence: 25-50mg PO daily OR 380mg IM q4w",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Safety/efficacy not established",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "",
      "subsections": {
        "Pregnancy_Rating": {
          "text": "Category C",
          "tables": []
        },
        "Lactation_risk": {
          "text": "Minimally excreted in breastmilk",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "Use caution",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Use caution",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pregnancy_Rating": {
      "text": "Category C",
      "subsections": {
        "Lactation_risk": {
          "text": "Minimally excreted in breastmilk",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "Use caution",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Use caution",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Lactation_risk": {
      "text": "Minimally excreted in breastmilk",
      "subsections": {
        "Renal_Dosing": {
          "text": "Use caution",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Use caution",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Renal_Dosing": {
      "text": "Use caution",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "Use caution",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "Use caution",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nPatients who are on opioid analgesics/partial agonists, are opioid-dependant, or in acute opioid withdrawal",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Depression, suicide, and suicidality\nVulnerability to opioid overdose: Patients should be alerted that they may be more sensitive to opioids, even at lower doses, after discontinuance of naltrexone\nHepatotoxicity\nSevere injection-site reactions (e.g. necrosis, cellulitis, hematoma)",
          "tables": []
        },
        "Common": {
          "text": "Injection site reaction\nNausea/vomiting, diarrhea, decreased appetite, dry mouth\nLFT abnormalities,\nElevated CPK\nHeadache, dizziness, anxiety, insomnia, somnolence\nURI, pharyngitis\nArthralgia, muscle cramps, back pain\nRash",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Depression, suicide, and suicidality\nVulnerability to opioid overdose: Patients should be alerted that they may be more sensitive to opioids, even at lower doses, after discontinuance of naltrexone\nHepatotoxicity\nSevere injection-site reactions (e.g. necrosis, cellulitis, hematoma)",
      "subsections": {
        "Common": {
          "text": "Injection site reaction\nNausea/vomiting, diarrhea, decreased appetite, dry mouth\nLFT abnormalities,\nElevated CPK\nHeadache, dizziness, anxiety, insomnia, somnolence\nURI, pharyngitis\nArthralgia, muscle cramps, back pain\nRash",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Injection site reaction\nNausea/vomiting, diarrhea, decreased appetite, dry mouth\nLFT abnormalities,\nElevated CPK\nHeadache, dizziness, anxiety, insomnia, somnolence\nURI, pharyngitis\nArthralgia, muscle cramps, back pain\nRash",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: PO- 4-13h;IM- 5-10 days\nMetabolism: Hepatic\nExcretion: Urinary",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Potent nonselective opioid competitive receptor antagonist\nReduces the rewarding effects of alcohol consumption  by inhibiting the activity of endogenous opioids in the mesolimbic system.\n[1]",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Opioids",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Opioids",
          "url": "https://wikem.org/wiki/Opioids"
        }
      ]
    }
  }
}